Philippe Solal-Céligny Selected Research

Philippe Solal-Céligny Research Topics

10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 04/2002
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2017 - 11/2002
6	Lymphoma (Lymphomas) 01/2018 - 11/2002
5	Neoplasms (Cancer) 01/2017 - 04/2002
2	Neutropenia 01/2017 - 06/2003
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 03/2006
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2013 - 07/2013
2	Disease Progression 07/2008 - 09/2007
1	Hodgkin Disease (Hodgkin's Disease) 01/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2010

16	Rituximab (Mabthera)FDA Link 01/2018 - 04/2002
6	Monoclonal AntibodiesIBA 01/2014 - 07/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 07/2008
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 07/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 07/2008
2	obinutuzumabIBA 08/2013 - 08/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2013 - 11/2002
2	Prednisolone (Predate)FDA LinkGeneric 07/2008 - 11/2002
1	Biosimilar PharmaceuticalsIBA 01/2017
1	Filgrastim (Neupogen)FDA Link 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	lucatumumabIBA 01/2014
1	Ifosfamide FDA LinkGeneric 07/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2013
1	Serum AlbuminIBA 11/2012
1	CD20 AntigensIBA 01/2011
1	Surface Antigens (Surface Antigen)IBA 04/2010
1	fludarabineIBA 04/2010
1	InterferonsIBA 07/2008
1	Teniposide (VM 26)FDA Link 07/2008
1	purineIBA 07/2003
1	Chlorambucil (Leukeran)FDA Link 11/2002